HORMAD1 and cancer: A GSEA analysis revealed that the “HORMAD1 + CT83” signature detected in HMLE cells was significantly correlated to the transcriptome profile of double-positive cancer cell lines (Fig. 6M, upper panel) and with the transcriptome of double-positive tumors (Fig. 6M, lower panel).